Ocean Genomics is transforming drug discovery and development, and precision medicine through our Intelligent Transcriptome.

We work with biopharma and diagnostics companies, and academic researchers to discover biomarkers and drug targets, determine mechanism of action and biological impact, inform selection of candidate assets, inform trial design, and provide subpopulation analysis / biomarker mining for trial salvage and back translation.

Ocean provides its unique, proprietary platforms and capabilities to understand and predict the biological impact of diseases and therapies.
- comprehensive transcriptome pipeline with enhanced molecular feature extraction and functional profiling
- advanced, automated machine learning (ML) biomarker discovery platform across multiple forms of data and -omics
- world-class computational biology, transcriptomics and AI team

Spun out of Carnegie Mellon University Dr. Carl Kingsford’s lab in 2018.